We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release

All Resources

Approaching Viral Vector Manufacturing With An Emphasis On Quality & Design

May 10, 2022

Adapting an existing facility for viral vector manufacturing purposes presents challenges that have the potential to impact safety and integrity. A dedicated facility, built from the ground up, enables CDMOs to address areas of concern specific to viral vectors. Learn more about how Avid’s purpose-built approach is answering the industry need for quality viral vector manufacturing.

All Resources

Approaching Viral Vector Manufacturing With An Emphasis On Quality & Design

Sign up for Avid emails.

Follow Us:

Get the latest from Avid.

Follow Us:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content: